1. Feuerstein G, Hunter J, Barone FC. Calcium channel blockers and neuroprotection. Emerg Strateg Neuroprotection. 2013; 129-50. [ DOI:10.1007/978-1-4684-6796-3_8] 2. Nimmrich V, Eckert A. Calcium channel blockers and dementia. Br J Pharmacol. 2013; 169: 1203-10. [ DOI:10.1111/bph.12240] 3. Chiozzi P, Sarti AC, Sanz JM, Giuliani AL, Adinolfi E, Vultaggio-Poma V, et al. Amyloid β-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine. Sci Rep. 2019; 9: 6475. [ DOI:10.1038/s41598-019-42931-2] 4. Heale R. Dementia care and treatment issues. Evid Based Nurs. 2020; 23: 40-2. [ DOI:10.1136/ebnurs-2020-103260] 5. Freir DB, Costello DA, Herron CE. Aβ25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J Neurophysiol. 2003; 89: 3061-9. [ DOI:10.1152/jn.00992.2002] 6. Schmidtko A, Lötsch J, Freynhagen R. Ziconotide for treatment of severe chronic pain. Lancet. 2010; 375: 1569-77. [ DOI:10.1016/S0140-6736(10)60354-6] 7. Skov MJ, Beck JC, de Kater AW. Nonclinical safety of ziconotide: an intrathecal analgesic of a new pharmaceutical class. Int J Toxicol. 2007; 26: 411-21. [ DOI:10.1080/10915810701582970] 8. Bozorgi H, Jahanian-Najafabadi A, Rabbani. The effect of intrathecal administration of the neuronal N-type calcium channels antagonist, ω-conotoxin MVIIA, on attenuating the spontaneous and naloxone-precipitated morphine withdrawal in rats. Toxin Rev. 2016; 35: 33-7. [ DOI:10.1080/15569543.2016.1181657] 9. Bozorgi H, Jahanian-Najafabadi A, Rabbani M. Effect of N-type calcium channel blocker Ziconotide on memory in rats following morphine withdrawal. Online J Vet Res. 2016; 20: 335-44. 10. Bozorgi H, Motaghi E, Zamani M, Ghavimi R. Neuronal calcium channels blocker, ziconotide (ɷ-conotoxin MVIIA), reverses morphine withdrawal-induced memory impairments via alteration in hippocampal NMDA receptor expression in rats. Toxin Rev. 2018; 38: 1-10. [ DOI:10.1080/15569543.2018.1525402] 11. Bozorgi H, Budde T, Nankali M. Antidepressant-like and memory-enhancing effects of the N-type calcium channel blocker, ziconotide in rats. Behav Brain Res. 2020; 390. [ DOI:10.1016/j.bbr.2020.112647] 12. Deutschenbaur L, Beck J, Kiyhankhadiv A, Mühlhauser M, Borgwardt S, Walter M, et al. Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog Neuropsychopharmacol Biol Psychiatry. 2016; 64: 325-33. [ DOI:10.1016/j.pnpbp.2015.02.015] 13. Hannon HE, Atchison WD. Omega-Conotoxins as Experimental Tools and Therapeutics in Pain Management. Mar Drugs. 2013; 11: 680-99. [ DOI:10.3390/md11030680] |
